Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
Clinical trial NCT01693614 · COMPLETED
Trial details
- NCT number
- NCT01693614
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-28
- Primary completion
- 2017-07-21
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.